|
|
||||||||
Journal of Lipid Research, Vol 24, 1419-1428, Copyright © 1983 by Lipid Research, Inc.
JM Bailey, RW Bryant, J Whiting and K Salata
Arachidonic acid is the precursor of several potent derivatives that
regulate physiological functions in the cardiovascular system. Thromboxane
(TXA2) and prostacyclin (PGI2) are synthesized by the cyclooxygenase
enzyme. The proaggregatory and vasoconstrictive TXA2 produced by platelets
is opposed in vivo by the antiaggregatory and vasodilating activity of PGI2
synthesized by blood vessels. Arachidonic acid is also converted via a
5-lipoxygenase to leukotrienes, the vasoconstrictive components of SRSA. We
have shown that this latter pathway is regulated by 15-HETE, a product of
the 15-lipoxygenase present in lymphocytes. Confluent cultures of rat aorta
smooth muscle cells (RSM) were superfused briefly with [14C]arachidonic
acid. The products were isolated and analyzed by thin-layer chromatography-
radioautography, high performance liquid chromatography, and gas-liquid
chromatography-mass spectrometry. Prostacyclin (PGI2) was identified as the
major product both by its biological properties in a platelet aggregation
assay and by the mass spectrum of its tetra- trimethylsilylether-methyl
ester derivative. Minor quantities of PGE2, PGD2, and PGF2 alpha were also
synthesized. Three other compounds with chromatographic properties of
mono-hydroxy eicosanoic acids were also formed in major amounts. These were
shown to be cyclooxygenase products since their synthesis, together with
that of prostacyclin, was blocked by the cyclooxygenase inhibitors aspirin
(0.2 mM) and indomethacin (10 microM). Quantities of the
hydroxy-eicosanoids were isolated from large scale incubations by silicic
acid chromatography. Following methylation and reduction with platinum
oxide/H2, the compounds were converted to their trimethylsilylether
derivatives and analyzed by gas-liquid chromatography-mass spectrometry.
The compounds were identified as 11- hydroxy-5,8,12,14-eicosatetraenoic
acid (11-HETE), 15-hydroxy-5,8,11,13- eicosatetraenoic acid (15-HETE), and
hydroxy-5,8,10-heptadeca-trienoic acid (HHT) by simultaneous ion monitoring
of characteristic ions at M/e ratios of 287, 258, 229 for 11-HETE and 343,
314, 173 for 15-HETE, and by comparison with the mass spectra of authentic
samples. Rat smooth muscle cells, prelabeled by 24-hour incubation with
[14C]arachidonic acid, released large amounts of prostacyclin together with
enhanced amounts of 11- and 15-HETE in response to physiological levels of
thrombin (0.5-5 units/ml). These experiments demonstrate that, in addition
to the thromboxane antagonist prostacyclin, vascular smooth muscle cells
produce significant quantities of the leukotriene inhibitor 15-HETE via the
cyclooxygenase pathway in response to physiological stimuli such as
thrombin. The release of both prostacyclin and 15-HETE by vascular smooth
muscle cells may thus play an important role in vascular homeostasis.
ARTICLES
Characterization of 11-HETE and 15-HETE, together with prostacyclin, as major products of the cyclooxygenase pathway in cultured rat aorta smooth muscle cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Zhu, M. Bousamra II, D. C. Zeldin, J. R. Falck, M. Townsley, D. R. Harder, R. J. Roman, and E. R. Jacobs Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L335 - L343. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |